Could investigational drug become first-in-class bronchiectasis therapy?
By Catherine Eckford (European Pharmaceutical Review)
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
By Catherine Eckford (European Pharmaceutical Review)
Antibody treatment demonstrates potential in lupus kidney disease
By Catherine Eckford (European Pharmaceutical Review)
FDA approves novel therapy for chronic skin condition
By Catherine Eckford (European Pharmaceutical Review)
QbD for biopharmaceutical product lifecycle management
By Busol Park (Samsung Biologics), Youngsun Kim (Samsung Biologics)
Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing
By Andy Kavanagh (MSD Ireland), John Corcoran (MSD Ireland), Oliver…